Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'ZHANG RW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wang, H; Nan, L; Yu, D; Agrawal, S; Zhang, RW
      Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: In vitro and in vivo activities and mechanisms

      CLINICAL CANCER RESEARCH
    2. Platzer, P; Thalhammer, T; Reznicek, G; Hamilton, G; Zhang, RW; Jager, W
      Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver

      INTERNATIONAL JOURNAL OF ONCOLOGY
    3. Zhang, RW; Wang, H
      MDM2 oncogene as a novel target for human cancer therapy

      CURRENT PHARMACEUTICAL DESIGN
    4. Sellers, RS; Zhang, RW; Glasson, SS; Kim, HD; Peluso, D; D'Augusta, DA; Beckwith, K; Morris, EA
      Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2)

      JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
    5. Chen, LH; Lu, WG; Agrawal, SH; Zhou, WQ; Zhang, RW; Chen, JD
      Ubiquitous induction of p53 in tumor cells by antisense inhibition of MDM2expression

      MOLECULAR MEDICINE
    6. Wang, H; Zeng, XF; Oliver, P; Le, LP; Chen, JD; Chen, LH; Zhou, WQ; Agrawal, S; Zhang, RW
      MDM2 oncogene as a target for cancer therapy: An antisense approach

      INTERNATIONAL JOURNAL OF ONCOLOGY
    7. Wang, H; Cai, QY; Zeng, XF; Yu, D; Agrawal, S; Zhang, RW
      Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RI alpha subunit of protein kinase A after oraladministration

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. LU ZH; ZHANG RW; CARPENTER JT; DIASIO RB
      DECREASED DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN A POPULATION OFPATIENTS WITH BREAST-CANCER - IMPLICATION FOR 5-FLUOROURACIL-BASED CHEMOTHERAPY

      Clinical cancer research
    9. LU ZH; ZHANG RW; CARPENTER JT; DIASIO RB
      DECREASED DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN A POPULATION OFPATIENTS WITH BREAST-CANCER - IMPLICATION FOR 5-FLUOROURACIL-BASED CHEMOTHERAPY

      Clinical cancer research
    10. AGRAWAL S; ZHANG XS; CAI QY; KANDIMALLA ER; MANNING A; JIANG ZW; MARCEL T; ZHANG RW
      EFFECT OF ASPIRIN ON PROTEIN-BINDING AND TISSUE DISPOSITION OF OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS

      Journal of drug targeting
    11. LIU WM; ZHANG RW
      UP-REGULATION OF P21(WAF1 CIP1) IN HUMAN BREAST-CANCER CELL-LINES MCF-7 AND MDA-MB-468 UNDERGOING APOPTOSIS INDUCED BY NATURAL PRODUCT ANTICANCER DRUGS 10-HYDROXYCAMPTOTHECIN AND CAMPTOTHECIN THROUGH P53-DEPENDENT AND INDEPENDENT PATHWAYS/

      International journal of oncology
    12. Zhang, RW; Ji, WY; Lu, BY
      Emergence and development of agro-ecological engineering in China

      ECOLOGICAL ENGINEERING
    13. ZHANG RW; LI YF; CAI QY; LIU TP; SUN H; CHAMBLESS B
      PRECLINICAL PHARMACOLOGY OF THE NATURAL PRODUCT ANTICANCER AGENT 10-HYDROXYCAMPTOTHECIN, AN INHIBITOR OF TOPOISOMERASE-I

      Cancer chemotherapy and pharmacology
    14. CHEN LH; AGRAWAL S; ZHOU WQ; ZHANG RW; CHEN JD
      SYNERGISTIC ACTIVATION OF P53 BY INHIBITION OF MDM2 EXPRESSION AND DNA-DAMAGE

      Proceedings of the National Academy of Sciences of the United Statesof America
    15. CAO H; ZHANG RW; SUNDAR CS; YUAN JP; HE Y; SANDRECZKI TC; JEAN YC; NIELSEN B
      DEGRADATION OF POLYMER COATING SYSTEMS STUDIED BY POSITRON-ANNIHILATION SPECTROSCOPY - 1 - UV IRRADIATION EFFECT

      Macromolecules
    16. COBOS JA; YANG JP; ZHANG RW; KRUKOWSKI M; SIMMONS DJ
      POSITIVELY CHARGED DEXTRAN RESIN INHIBITS TRABECULAR BONE REPAIR IN THE RABBIT TIBIAL PHYSIS

      Journal of biomedical materials research
    17. DIASIO RB; ZHANG RW
      PHARMACOLOGY OF THERAPEUTIC OLIGONUCLEOTIDES

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    18. AGRAWAL S; TAN WT; CAI QY; XIE XW; ZHANG RW
      IN-VIVO PHARMACOKINETICS OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES CONTAINING CONTIGUOUS GUANOSINES

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    19. ZHANG RW; CAI QY; LINDSEY JR; LI YF; CHAMBLESS B; NAGUIB FNM
      ANTITUMOR-ACTIVITY AND PHARMACOKINETICS FOLLOWING ORAL-ADMINISTRATIONOF NATURAL PRODUCT DNA TOPOISOMERASE-I INHIBITORS 10-HYDROXYCAMPTOTHECIN AND CAMPTOTHECIN IN SCID MICE BEARING HUMAN BREAST-CANCER XENOGRAFTS

      International journal of oncology
    20. CAI QY; LINDSEY R; ZHANG RW
      REGRESSION OF HUMAN COLON-CANCER XENOGRAFTS IN SCID MICE FOLLOWING ORAL-ADMINISTRATION OF WATER-INSOLUBLE CAMPTOTHECINS

      International journal of oncology
    21. SONG H; REN SX; XIA F; ZHANG RW; WEI CM
      EXPRESSION OF P53 PROTEIN IN HUMAN CARDIAC TISSUE WITH CONGESTIVE-HEART-FAILURE

      The FASEB journal
    22. CAI QY; RAHN RO; ZHANG RW
      DIETARY FLAVONOIDS, QUERCETIN, LUTEOLIN AND GENISTEIN, REDUCE OXIDATIVE DNA-DAMAGE AND LIPID-PEROXIDATION AND QUENCH FREE-RADICALS

      Cancer letters
    23. JEAN YC; ZHANG RW; CAO H; YUAN JP; HUANG CM; NIELSEN B; ASOKAKUMAR P
      GLASS-TRANSITION OF POLYSTYRENE NEAR-THE-SURFACE STUDIED BY SLOW-POSITRON-ANNIHILATION SPECTROSCOPY

      Physical review. B, Condensed matter
    24. AGRAWAL S; JIANG ZW; ZHAO QY; SHAW D; CAI QY; ROSKEY A; CHANNAVAJJALA L; SAXINGER C; ZHANG RW
      MIXED-BACKBONE OLIGONUCLEOTIDES AS SECOND GENERATION ANTISENSE OLIGONUCLEOTIDES - IN-VITRO AND IN-VIVO STUDIES

      Proceedings of the National Academy of Sciences of the United Statesof America
    25. LI YF; ZHANG RW
      REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY METHOD FOR THE SIMULTANEOUS QUANTITATION OF THE LACTONE AND CARBOXYLATE FORMS OF THE NOVEL NATURAL PRODUCT ANTICANCER AGENT 10-HYDROXYCAMPTOTHECIN IN BIOLOGICAL-FLUIDS AND TISSUES

      Journal of chromatography B. Biomedical applications
    26. TAKIMOTO CH; LU ZH; ZHANG RW; LIANG MD; LARSON LV; CANTILENA LR; GREM JL; ALLEGRA CJ; DIASIO RB; CHU E
      SEVERE NEUROTOXICITY FOLLOWING 5-FLUOROURACIL-BASED CHEMOTHERAPY IN APATIENT WITH DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY

      Clinical cancer research
    27. WANG Q; ZHOU BN; ZHANG RW; LIN YY; LIN LZ; GIL RR; CORDELL GA
      CYTOTOXICITY AND NMR SPECTRAL ASSIGNMENTS OF ERGOLIDE AND BIGELOVIN

      Planta medica
    28. ZHANG RW; IYER RP; YU D; TAN WT; ZHANG XS; LU ZH; ZHAO H; AGRAWAL S
      PHARMACOKINETICS AND TISSUE DISPOSITION OF A CHIMERIC OLIGODEOXYNUCLEOSIDE PHOSPHOROTHIOATE IN RATS AFTER INTRAVENOUS ADMINISTRATION

      The Journal of pharmacology and experimental therapeutics
    29. ZHANG XS; ZHANG RW; ZHAO H; CAI HY; GUSH KA; KERR RG; PETTIT GR; KRAFT AS
      PRECLINICAL PHARMACOLOGY OF THE NATURAL PRODUCT ANTICANCER AGENT BRYOSTATIN-1, AN ACTIVATOR OF PROTEIN-KINASE-C

      Cancer research
    30. ZHANG RW; SUPOWIT SC; KLEIN GL; LU ZF; CHRISTENSEN MD; LOZANO R; SIMMONS DJ
      RAT TAIL SUSPENSION REDUCES MESSENGER-RNA LEVEL FOR GROWTH-FACTORS AND OSTEOPONTIN AND DECREASES THE OSTEOBLASTIC DIFFERENTIATION OF BONE-MARROW STROMAL CELLS

      Journal of bone and mineral research
    31. SEITZ PK; ZHANG RW; SIMMONS DJ; COOPER CW
      EFFECTS OF C-TERMINAL PARATHYROID HORMONE-RELATED PEPTIDE ON OSTEOBLASTS

      Mineral and electrolyte metabolism
    32. ZHANG RW; SUPOWIT SC; XU X; LI H; CHRISTENSEN MD; LOZANO R; SIMMONS DJ
      EXPRESSION OF SELECTED OSTEOGENIC MARKERS IN THE FIBROBLAST-LIKE CELLS OF RAT MARROW STROMA

      Calcified tissue international
    33. LU ZH; ZHANG RW; DIASIO RB
      POPULATION CHARACTERISTICS OF HEPATIC DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY, A KEY METABOLIC ENZYME IN 5-FLUOROURACIL CHEMOTHERAPY

      Clinical pharmacology and therapeutics
    34. ZHANG RW; YAN JM; SHAHINIAN H; AMIN G; LU ZH; LIU TP; SAAG MS; JIANG ZW; TEMSAMANI J; MARTIN RR; SCHECHTER PJ; AGRAWAL S; DIASIO RB
      PHARMACOKINETICS OF AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) IN HIV-INFECTED SUBJECTS

      Clinical pharmacology and therapeutics
    35. ZHANG RW; LU ZH; ZHANG XS; ZHAO H; DIASIO RB; LIU TP; JIANG ZW; AGRAWAL S
      IN-VIVO STABILITY AND DISPOSITION OF A SELF-STABILIZED OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE IN RATS

      Clinical chemistry
    36. ZHANG RW; LU ZH; ZHAO H; ZHANG XS; DIASIO RB; HABUS I; JIANG ZW; IYER RP; YU D; AGRAWAL S
      IN-VIVO STABILITY, DISPOSITION AND METABOLISM OF A HYBRID OLIGONUCLEOTIDE PHOSPHOROTHIOATE IN RATS

      Biochemical pharmacology
    37. AGRAWAL S; ZHANG XS; LU ZH; ZHAO H; TAMBURIN JM; YAN YM; CAI HY; DIASIO RB; HABUS I; JIANG ZW; IYER RP; YU D; ZHANG RW
      ABSORPTION, TISSUE DISTRIBUTION AND IN-VIVO STABILITY IN RATS OF A HYBRID ANTISENSE OLIGONUCLEOTIDE FOLLOWING ORAL-ADMINISTRATION

      Biochemical pharmacology
    38. ZHANG RW; DIASIO RB; LU ZH; LIU TP; JIANG ZW; GALBRAITH WM; AGRAWAL S
      PHARMACOKINETICS AND TISSUE DISTRIBUTION IN RATS OF AN OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) DEVELOPED AS A THERAPEUTIC AGENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Biochemical pharmacology
    39. ZHANG RW; LU ZH; ZHANG XS; DIASIO RB; JIANG ZW; AGRAWAL S
      IN-VIVO BIOSTABILITY, PHARMACOKINETICS, AND DISPOSITION IN RATS OF A SELF-STABILIZED ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE

      Clinical chemistry
    40. ZHANG RW; SUPOWIT S; SIMMONS DJ
      OSTEOGENIC ROLE OF BONE-MARROW STROMAL CELLS

      Journal of bone and mineral research
    41. SPARANO JA; WADLER S; DIASIO RB; ZHANG RW; LU ZH; SCHWARTZ EL; EINZIG A; WIERNIK PH
      PHASE-I TRIAL OF LOW-DOSE, PROLONGED CONTINUOUS-INFUSION FLUOROURACILPLUS INTERFERON-ALFA - EVIDENCE FOR ENHANCED FLUOROURACIL TOXICITY WITHOUT PHARMACOKINETIC PERTURBATION

      Journal of clinical oncology
    42. ZHANG RW; LU ZH; DIASIO CR; LIU TP; SOONG SJ
      THE TIME OF ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE (AZT) DETERMINES ITS HOST TOXICITY WITH POSSIBLE RELEVANCE TO AZT CHEMOTHERAPY

      Antimicrobial agents and chemotherapy
    43. LU ZH; ZHANG RW; DIASIO RB
      DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND LIVER - POPULATION CHARACTERISTICS, NEWLY IDENTIFIED DEFICIENT PATIENTS, AND CLINICAL IMPLICATION IN 5-FLUOROURACIL CHEMOTHERAPY

      Cancer research
    44. ZHANG RW; LU ZH; LIU TP; SOONG SJ; DIASIO RB
      RELATIONSHIP BETWEEN CIRCADIAN-DEPENDENT TOXICITY OF 5-FLUORODEOXYURIDINE AND CIRCADIAN-RHYTHMS OF PYRIMIDINE ENZYMES - POSSIBLE RELEVANCE TO FLUOROPYRIMIDINE CHEMOTHERAPY

      Cancer research
    45. LU ZH; ZHANG RW; DIASIO RB
      COMPARISON OF DIHYDROPYRIMIDINE DEHYDROGENASE FROM HUMAN, RAT, PIG AND COW LIVER - BIOCHEMICAL AND IMMUNOLOGICAL PROPERTIES

      Biochemical pharmacology
    46. ZHANG RW; LIU TP; SOONG SJ; DIASIO RB
      A MATHEMATICAL-MODEL OF THE KINETICS AND TISSUE DISTRIBUTION OF 2-FLUORO-BETA-ALANINE, THE MAJOR CATABOLITE OF 5-FLUOROURACIL

      Biochemical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 16:41:16